AVLS
John Blebea, MD, MBA
Clinical Professor of Surgery
Central Michigan University
Central Michigan University
Saginaw, MI, United States
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Robert White, MHS
Director, Healthcare Policy & Advocacy
American Vein & Lymphatic Society
Chicago, IL, United States
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
The session will provide attendees with both an update on AVLS advocacy initiatives during the past year as well as insights on the effects of recent Medicare physician reimbursements cuts, new CMS models on health care delivery, and maintaining compliance with reimbursement requirements.
Program Chair: John Blebea, MD, MBA – Central Michigan University
Co-Chair: Robert White, MHS – American Vein & Lymphatic Society
Faculty: John Blebea, MD, MBA – Central Michigan University
Faculty: Ellen Lukens, CMS,CMMI
Moderator: John Blebea, MD, MBA – Central Michigan University
Moderator: Robert White, MHS – American Vein & Lymphatic Society
Faculty: Courtney G. Tito, JD, Esq. – Michael Best & Friedrich LLP
Moderator: Courtney G. Tito, JD, Esq. – Michael Best & Friedrich LLP
Moderator: Robert White, MHS – American Vein & Lymphatic Society
Faculty: Robert White, MHS – American Vein & Lymphatic Society